KARL CHRISTOPH has a total of 22 patent applications. It decreased the IP activity by 81.0%. Its first patent ever was published in 2011. It filed its patents most often in Germany, EPO (European Patent Office) and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets medical technology, pharmaceuticals and materials and metallurgy are VERIGEN AG, SMITH & NEPHEW ORTHOPAEDICS AG and TISSUE REGENERATION SYSTEMS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | Germany | 5 | |
#2 | EPO (European Patent Office) | 5 | |
#3 | WIPO (World Intellectual Property Organization) | 5 | |
#4 | Taiwan | 3 | |
#5 | United States | 3 | |
#6 | Canada | 1 |
# | Industry | |
---|---|---|
#1 | Medical technology | |
#2 | Pharmaceuticals | |
#3 | Materials and metallurgy | |
#4 | Machines | |
#5 | Biotechnology | |
#6 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Implantable devices | |
#2 | Object sterilising | |
#3 | Additive manufacturing | |
#4 | Therapeutic chemical compounds | |
#5 | Medical preparations | |
#6 | Diagnosis and surgery | |
#7 | Climate change mitigation in goods production | |
#8 | Peptides | |
#9 | Alloys | |
#10 | Working metallic powder |
# | Name | Total Patents |
---|---|---|
#1 | Karl Christoph | 22 |
#2 | Ritter Zully | 4 |
#3 | Methner Vilma | 4 |
#4 | Urban Kathrin | 1 |
#5 | Thierolf Ruediger | 1 |
#6 | Ehrler Klaus | 1 |
#7 | Thierolf Rüdiger | 1 |
Publication | Filing date | Title |
---|---|---|
DE102018113809A1 | Joint implant for tissue regeneration at the joint | |
DE102018113580A1 | METHOD AND DEVICE FOR PRODUCING AN IMPLANT | |
EP3458093A1 | Pharmaceutical compositions with anti-rankl antibodies, calcium and vitamin d, suitable for the treatment and/or prophylaxis of disorders of the bone metabolism and therapy-induced side effects such as hypocalcemia | |
EP3246032A1 | Pharmaceutical compositions comprising zoledronic acid, calcium and vitamin d, suitable for the treatment and/or prophylaxis of diseases related to bone metabolism and of treatment-related side effects such as hypocalcaemia | |
DE102016124049A1 | Joint implant for tissue regeneration at the joint |